Alkermes plc. cotiza a 39.73 USD y tiene una capitalización bursátil de $6.7B. En los últimos 12 meses ha facturado $1.7B con un margen de flujo de caja libre del 32.5%. Cotiza a 30.1 veces su flujo de caja libre (P/FCF) y a un PER de 100.8. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the tre…
| Periodo | 2026-10 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.70 | $0.38 | $0.48 |
| Estimado | $0.25 | $0.29 | $-0.04 | $0.45 |
| Sorpresa | — | +141.4% | +1050.0% | +6.7% |
| Métrica | ALKS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 86.7% | 57.0% | +29.6% |
| Operating Margin | 17.2% | -38.6% | +55.8% |
| Net Margin | 16.4% | -33.6% | +49.9% |
| FCF Margin | 32.5% | -13.9% | +46.4% |
| ROE | 13.3% | -40.4% | +53.7% |
| ROA | 9.7% | -32.0% | +41.7% |
| Current Ratio | 3.55 | 2.84 | +0.71 |
| Debt / Equity | — | 0.28 | — |